This Food Stock Is a Buy. It Rarely Pays to Bet Against the American Eater
Published
The “Ozempic effect” and flagging investor interest in traditional consumer staples have weighed on PepsiCo stock this year. But the impact of weight-loss drugs on PepsiCo’s snack-food and beverage franchise will likely be minimal.
#pepsico